Skip to Main Content

Paper Details

Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics.
J Ovarian Res
7
2021
-catenin, HGSOC, HGSOC cancer, HGSOC cancer cells, HGSOC cells, NF-B, PARP, PARP1, PARP1i, PARPi, Poly (ADP)-ribose, Poly (ADP)-ribose polymerase, SP1, TVB-2640, fatty acid, fatty acid synthase, high-grade serous ovarian cancer, ovarian, ovarian cancer, ovarian cancer cells, tumor
Author NameAffiliation
Fabian CosciaNNF Center for Protein Research, University of Copenhagen
Matthias MannNNF Center for Protein Research, University of Copenhagen
Matthias MannMax Planck Institute of Biochemistry
Matthias MannNNF Center for Protein Research, University of Copenhagen
Matthias MannMax Planck Institute of Biochemistry
Chris SanderDana-Farber Cancer Institute
Chris SanderHarvard Medical School
Chris SanderBroad Institute of Harvard and MIT
Chris SanderDana-Farber Cancer Institute
Chris SanderHarvard Medical School
Chris SanderBroad Institute of Harvard and MIT
  • 1 - 11

Datasets

Release 1.2